# Venkat Srinivasan

> Venkat Srinivasan is a seed investor at Innospark Ventures backing Software. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Innospark Ventures](https://shizune.co/investors/profile/innospark-ventures)
- Location: Boston, United States
- Total investments: 11
- Last investment: Jun 2025
- Lead investor: 64%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/venkat-srinivasan-111510a
- X (Twitter): https://twitter.com/venkatrage
- Website: https://x.com/venkat_srini_

Venkat Srinivasan is a seed investor at Innospark Ventures in Boston focused on Software and Information Technology. Venkat Srinivasan is the Founder and Exec Chair of Gyan. He previously worked at Rage Frameworks as a CEO. Venkat Srinivasan attended the University of Cincinnati Carl H. Lindner College of Business.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 3 | 27% |
| Information Technology | 3 | 27% |
| Medical | 2 | 18% |
| Health Care | 2 | 18% |
| Medical Device | 2 | 18% |

26 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 6 | 55% |
| Pre-Seed | 1 | 9% |
| Series A | 1 | 9% |
| Venture - Series Unknown | 1 | 9% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 5 | 45% |
| India | 3 | 27% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ArrePath | ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections. |  | Seed | Jun 23, 2025 |  |
| AirWorks | AirWorks was founded in 2017, and spun out of MIT in the summer of 2018. The company has developed a patented algorithm and web application that converts aerial datasets into engineering base plans in CAD. This way, clients don't need any local processing resources, virtually no training and thanks to the automation we ensure the fastestturn-around times in the industry – saving hundred millions of hours of manual data labeling time. | $5M | Venture - Series Unknown | Jul 01, 2022 |  |
| Text Mercato | Text Mercato is a technology-based content writing solution provider that helps develop content using a custom-built platform and algorithms to deliver quality work. It is a provider of content writing and distribution services used to help eCommerce platforms to onboard sellers and catalog their products. It provides analytical reporting on thecontent in terms of rating, English quality, word density, blacklisted words, and recommends words. Also, it provides copywriting services on the content developed. Its pricing is based on the type of content, the quality expected, the size of the order, and the timelines.Text Mercato was established in 2015 and is headquartered in Bangalore, Karnataka. | $2.6M | Seed | Jun 06, 2022 |  |
| Rubick.ai | Rubick, established in 2015 is one of the fastest-growing eCommerce enablement platforms leveraging AI to automate the catalog creation. We specialize in cataloging and digital readiness for marketplaces, brands, and sellers. Rubick is a one-stop solution platform for brick-and-mortar Marketplaces & Online businesses. We offer an end-to-endfull-stack Product Information, Cataloging, and Marketing platform as a solution for your eCommerce business. Rubick has cataloged over 7Mn SKUs for brands like Decathlon, Just In Time, Amazon, Hudson Bay US, Adidas, TLC UAE, and many more. | $2.6M | Seed | Jun 06, 2022 |  |
| ZETA SURGICAL | Next-Generation Surgical Navigation and Robotics | $8.8M | Seed | Mar 10, 2022 |  |
| ArrePath | ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections. | $20M | Seed | Mar 03, 2022 |  |
| Entri | Entri is a vernacular language learning platform for teachers and students. Up to 750k students and 2300 teachers have used Entri to improve their learning and teaching so far. | $7.1M | Series A | Feb 16, 2022 |  |
| Encora Therapeutics | Encora is a MIT spin-off company innovating solutions for neurological movement disorders. | $1.5M | Pre-Seed | Sep 30, 2020 |  |
| AirWorks | AirWorks was founded in 2017, and spun out of MIT in the summer of 2018. The company has developed a patented algorithm and web application that converts aerial datasets into engineering base plans in CAD. This way, clients don't need any local processing resources, virtually no training and thanks to the automation we ensure the fastestturn-around times in the industry – saving hundred millions of hours of manual data labeling time. | $2.7M | Seed | Sep 17, 2020 |  |
| VODA.ai | VODA.ai serves water utilities by helping them assess the condition of their pipes with affordable software that ranks pipes by Business Risk Exposure (BRE) which includes Likelihood of Failure (LoF) and Consequence of Failure (CoF). This helps utilities prioritize capital investments, conserve water, and save money in operations. Customers includelarge metropolitan cities like Las Vegas and Boston. |  | Seed | Feb 26, 2020 |  |

10 of 11 investments shown.

## Co-investors
- [MetaProp](https://shizune.co/investors/profile/metaprop-nyc) — VC Fund, 3 deals together
- [1Crowd](https://shizune.co/investors/profile/1crowd) — VC Fund, 2 deals together
- [ah! Ventures](https://shizune.co/investors/profile/ahventures) — VC Fund, 2 deals together
- [Boehringer Ingelheim Venture Fund](https://shizune.co/investors/profile/boehringer-ingelheim-venture-fund) — VC Fund, 2 deals together
- [Creative Ventures](https://shizune.co/investors/profile/creative-ventures) — VC Fund, 2 deals together
- [Insight Partners](https://shizune.co/investors/profile/insight-partners) — VC Fund, 2 deals together

## About Innospark Ventures

VC Fund · Boston, United States

Innospark Ventures is a new breed of early-stage venture capital firm, investing in the AI-driven economy.

3 contacts available at Innospark Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Matt Fates | Partner - AI VC | https://shizune.co/investors/profile/matt-fates |
| Mark Legare | Venture Investor | https://shizune.co/investors/profile/mark-legare |
| Venkat Srinivasan | Managing Director | https://shizune.co/investors/profile/venkat-srinivasan |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Venkat Srinivasan invest in?

Venkat Srinivasan invests primarily in Software, Information Technology and Medical startups, most often at Seed and Pre-Seed stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Venkat Srinivasan last invest?

The most recent investment recorded for Venkat Srinivasan closed in Jun 2025. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co